Childhood Cancers | Tumor

CURE’s childhood cancers page is a go-to resource for oncology news and updates in the world of childhood cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in childhood cancers.

FDA Approves Ojemda for Pediatric Low-Grade Glioma

April 23rd 2024, 7:01pm

Article

The FDA has granted accelerated approval to Ojemda for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with a BRAF fusion or rearrangement, or BRAF V600 mutation.

FDA Approves Lutathera for Pediatric GEP-NETs

April 23rd 2024, 4:38pm

Article

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.

Prisms of Sparkling Light Through Cancer's Storm

April 1st 2024, 1:00pm

Article

Cancer comes with an awful storm, but the prisms of light can make it a little less worse.

Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL

March 29th 2024, 1:00pm

Article

Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with relapsed or refractory B-ALL.

Music Therapy Helps Children With Cancer, Eases Caregiver Burden

March 26th 2024, 7:00pm

Article

Musical play engages children with cancer, which relieves stress for them and their parents/caregivers, an expert said.

FDA Grants Rare Pediatric Disease Designation to LSTA1 in Osteosarcoma

March 25th 2024, 10:00pm

Article

The investigational drug LSTA1 is being explored for the treatment of osteosarcoma, which starts in the bones and accounts for 2% of childhood cancers.

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

March 11th 2024, 1:00pm

Podcast

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Rhabdomyosarcoma Survivors May Have Poor Psychological Outcomes

March 7th 2024, 2:09pm

Article

Survivors of rhabdomyosarcoma may be at higher risk for poorer psychological outcomes, that radiation therapy and smoking may worsen.

FDA Approved Besponsa for Children With Acute Lymphoblastic Leukemia

March 6th 2024, 9:25pm

Article

The Food and Drug Administration approved Besponsa for pediatric patients aged 1 and older with relapsed or refractory CD22-positive, B-cell precursor ALL.

Remembering My Days as a Patient With Leukemia

March 5th 2024, 2:00pm

Article

“Waiting” described the waiting room at Children’s Hospital to get my chemotherapy. “My Days” was a remembrance of the year I was diagnosed with leukemia.